Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Axcella Health Inc (AXLA)

6   0 (0%) 06-01 11:09
Open: 6.2 Pre. Close: 6
High: 6.255 Low: 5.9
Volume: 123,319 Market Cap: 215M
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways. Axcella Health Inc. has a collaboration with CYTOO to explore impact of dysregulated metabolism on muscle physiology. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.196 - 6.22 6.22 - 6.247
Low: 5.55 - 5.574 5.574 - 5.601
Close: 5.953 - 5.994 5.994 - 6.04

Technical analysis

as of: 2020-06-01 10:55:53 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.03     One year: 10.55
Support: Support1: 5.36    Support2: 3.90
Resistance: Resistance1: 7.73    Resistance2: 9.03
Pivot: 5.31
Moving Average: MA(5): 5.66     MA(20): 5.45
MA(100): 4.32     MA(250): 5.63
MACD: MACD(12,26): 0.33     Signal(9): 0.30
Stochastic oscillator: %K(14,3): 52.23     %D(3): 45.64
RSI: RSI(14): 58.18
52-week: High: 15.05  Low: 2.25  Change(%): -59.7
Average Vol(K): 3-Month: 21650  10-Days: 58182

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AXLA has closed below upper band by 31.8%. Bollinger Bands are 105.3% wider than normal. The large width of the bands suggest high volatility as compared to AXLA's normal range. The bands have been in this wide range for 23 bars. This is a sign that the current trend might continue.

Headline News

Tue, 26 May 2020
Axcella Health Inc. [AXLA] stock Initiated by BTIG Research analyst, price target now $10 - The DBT News

Thu, 07 May 2020
Axcella Health Inc. [AXLA] Stock trading around $5.65 per share: What’s Next? - The DBT News

Fri, 22 May 2020
Chairman David Epstein Just Bought 73% More Shares In Axcella Health Inc. (NASDAQ:AXLA) - Yahoo Finance

Fri, 15 May 2020
Is Axcella Health (AXLA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Wed, 06 May 2020
Axcella Health Inc. (AXLA) moved up 32.72%: Axcella Health Inc. Price Paint Picture of volatility - State Reviewer

Thu, 28 May 2020
Do Analysts Expect Axcella Health Inc (AXLA) Stock to Rise Next Year? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 36
Shares Float (M) 15
% Held by Insiders 21.71
% Held by Institutions 63.07
Shares Short (K) 72
Shares Short P. Month (K) 156

Stock Financials

EPS -2.940
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.020
Profit Margin
Operating Margin
Return on Assets (ttm) -51.2
Return on Equity (ttm) -147.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.682
Qtrly Earnings Growth
Operating Cash Flow (M) -55
Levered Free Cash Flow (M) -34

Stock Valuations

PE Ratio -2.05
PEG Ratio
Price to Book value 2.99
Price to Sales
Price to Cash Flow -3.91

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.